The oral hypoxia-inducible factor prolyl hydroxylase inhibitor enarodustat counteracts alterations in renal energy metabolism in the early stages of diabetic kidney disease
| Autor: | Hasegawa, Sho, Tanaka, Tetsuhiro, Saito, Tomoyuki, Fukui, Kenji, Wakashima, Takeshi, Susaki, Etsuo A., Ueda, Hiroki R., Nangaku, Masaomi |
|---|---|
| Zdroj: | In Kidney International May 2020 97(5):934-950 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|